News > Biotechnology
Swansea University to Co-Host Inaugural Biopesticide Summit
Swansea University and Swansea University-based company Bionema Ltd are to host the inaugural Biopesticide Summit next year to address the pressing need to develop alternatives to chemical pesticides. The recent banning of chemical pesticides by the European Union (EU) and Environmental Protection Agency (EPA) suggests that there are significant risks to food security, human health…
Bionema Ltd and Swansea University to host inaugural Biopesticide Summit in 2019
Swansea University and Swansea University-based company Bionema Ltd are to host the inaugural Biopesticide Summit next year to address the pressing need to develop alternatives to chemical pesticides.
University think tank ready to share findings on future of health care
Academics at a top think tank are seeking talks with Welsh Health Secretary Vaughan Gething to discuss the future of health and social care in Wales.
Bionema & Biocatalysts win at Made in Wales Awards
The very best of the country's manufacturing sector have been celebrated at Insider's Made in Wales Awards 2018, with a roof rack maker, an organic pesticides specialist and a potato producer among the winners.
Cellesce and Cardiff University win Innovate UK Primer Award to develop Organoids at scale to advance Breast Cancer Research
Cellesce the cancer organoid bioprocessing company and Cardiff University have won an Innovate UK competition.
Biocatalysts plan £6m investment following acquisition
Specialist biotechnology company Biocatalysts, which was recently acquired by Brain AG, is investing £6m in expanding its manufacturing capacity.
Garlic extract recreated in lab for the very first time
An antibiotic compound commonly found in garlic has been recreated by researchers for the very first time.
Bionema appoints Stephen Burt to its board
Bionema today announces the appointment of Stephen Burt as Finance Director.
Bionema backed by private investors
Bionema has received backing from an overseas private investor and the Development Bank of Wales as it looks to develop organic pesticides.
ReNeuron strikes US exclusivity deal
Cell-based therapeutics developer ReNeuron Group has signed an exclusivity agreement with a US pharmaceutical company for the potential out-licensing of its retinal stem cell technology.